Reference health
Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
40/40 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 40 checked references that resolve
resolves10.1001/archneurol.2008.505
Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis
resolves10.1186/s12974-017-0831-8
Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis
resolves10.1016/j.neuint.2013.10.008
Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica
resolves10.1001/jamaneurol.2016.6117
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
resolves10.1136/jnnp-2013-307454
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
resolves10.1080/14767058.2017.1344964
Increase of neuronal injury markers Tau and neurofilament light proteins in umbilical blood after intrapartum asphyxia
resolves10.3389/fneur.2018.00086
Raised Plasma Neurofilament Light Protein Levels Are Associated with Abnormal MRI Outcomes in Newborns Undergoing Therapeutic Hypothermia
resolves10.1016/j.jneuroim.2013.11.004
CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders
resolves10.1016/j.pediatrneurol.2013.02.015
Cerebrospinal Fluid Brain Injury Biomarkers in Children: A Multicenter Study
resolves10.1016/j.msard.2018.05.017
Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes
resolves10.1055/s-2001-20406
Glial Fibrillary Acidic Protein and Neurofilament in Children with Cerebral White Matter Abnormalities
resolves10.1002/ana.24954
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
resolves10.1212/NXI.0000000000000422
Neurofilament light chain predicts disease activity in relapsing-remitting MS
resolves10.1212/WNL.0000000000003653
Serum neurofilament is associated with progression of brain atrophy and disability in early MS
resolves10.1212/WNL.0000000000007032
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
resolves10.1177/1352458518765666
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
resolves10.1093/brain/awy154
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
resolves10.1093/brain/awy021
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
resolves10.1177/1352458518775303
High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome
resolves10.1177/1352458517715132
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
resolves10.1056/NEJMoa1800149
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis
resolves10.1177/2055217318778610
Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials
resolves10.1002/acn3.638
Neurofilament light chain serum levels correlate with 10‐year <scp>MRI</scp> outcomes in multiple sclerosis
resolves10.1038/nbt.1641
Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
resolves10.1515/cclm-2015-1195
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
resolves10.1371/journal.pone.0075091
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
resolves10.1177/1352458515623365
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
The 2 references without a DOI — listed, not checked
no DOI — not checkedHyun J-W, Kim Y, Kim G, Kim S-H, Kim HJ. Longitudinal analysis of serum neurofilament light chain: a potential therapeutic monitoring biomarker for multiple sclerosis. Mult Scler J 2019 Epub 2019 Mar 26.
no DOI — not checkedReiber H. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 2003;21:79–96.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1212/nxi.0000000000000749"><img src="https://citestamp.com/citestamped/10.1212/nxi.0000000000000749/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1212/nxi.0000000000000749)